Advos

Biomedical Research

News Category

Oncotelic Showcases AI-Driven Biomedical Discovery Platform at Drug Discovery 2026

Oncotelic Therapeutics presented its PDAOAI platform and a four-gene HCC signature at Drug Discovery 2026, highlighting a new approach to connect biom...

October 15, 2026Read the full article →

Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Services for Biomedical Research

Creative Biolabs has expanded its single-cell multi-omics and RNA sequencing solutions to help researchers overcome sample processing challenges and a...

September 14, 2026Read the full article →

Qdrant Powers Sapu AI Platform Indexing 28 Million PubMed Abstracts to Accelerate Cancer Research

Qdrant's vector search infrastructure enables Sapu's AI platform to index and query all 28 million PubMed abstracts, accelerating biomedical discovery...

May 12, 2026Read the full article →

Aclarion Adds First Private Practice Site in Los Angeles to CLARITY Trial, Aiming to Accelerate Enrollment

Aclarion, Inc. announced the addition of Lanman Spinal Neurosurgery, a private practice in Beverly Hills, to its CLARITY trial, which tests Nociscan's...

May 11, 2026Read the full article →

MilliporeSigma Expands Temecula Biotechnology Hub, Driving Innovation in Organoids and Personalized Medicine

MilliporeSigma's continued investment in its Temecula site, including the acquisition of HUB Organoids and a new organoid development lab, positions t...

May 5, 2026Read the full article →

Aclarion Expands Nociscan Use in Weill Cornell Spine Trial

Aclarion announced a second commercial agreement with Weill Cornell Medicine to use its Nociscan platform in a trial led by Dr. Roger Härtl studying b...

May 5, 2026Read the full article →